The protective role of Chinese prescription Kangen-karyu extract on diet-induced hypercholesterolemia in rats

Biological and Pharmaceutical Bulletin

Volumn 29, Issue 4, 2006, Pages 760-765

  Yokozawa, Takako ^a   Cho, Eun Ju ^b   Sasaki, Sumiyo ^a   Satoh, Akiko ^a   Okamoto, Takuya ^c   Sei, Yasuo ^c  

^a UNIVERSITY OF TOYAMA   (Japan)

^b Pusan National University   (South Korea)

^c Iskra Industry Co Ltd   (Japan)

Author keywords

Atherogenic index; Cholesterol; Coronary heart disease; Kangen karyu; Thiobarbituric acid reactive substance

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BIOLOGICAL MARKER; CHINESE DRUG; CHOLIC ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; KANGEN KARYU; LOW DENSITY LIPOPROTEIN CHOLESTEROL; THIOBARBITURIC ACID REACTIVE SUBSTANCE; UNCLASSIFIED DRUG;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; ATHEROGENESIS; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL LIVER LEVEL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; ENZYME ACTIVITY; FECES ANALYSIS; HEART PROTECTION; HISTOPATHOLOGY; HYPERCHOLESTEROLEMIA; ISCHEMIC HEART DISEASE; LIPID PEROXIDATION; LIVER INJURY; MALE; NONHUMAN; OXIDATION; RAT; WEIGHT CHANGE;

ALANINE TRANSAMINASE; ANIMALS; ASPARTATE AMINOTRANSFERASES; BODY WEIGHT; CHOLESTEROL, DIETARY; CHOLESTEROL, LDL; DIET; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUGS, CHINESE HERBAL; FECES; HYPERCHOLESTEROLEMIA; LIVER; MALE; ORGAN SIZE; OXIDATION-REDUCTION; PLANT EXTRACTS; RATS; RATS, WISTAR; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 33645553117     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.29.760     Document Type: Article

References (48)

1. Levine G. N., Keaney J. F., Vita J. A., N. Engl. J. Med., 332, 512-521 (1995).
2. Ballantyne C. M., Am. J. Cardiol., 82, 3Q-12Q (1998).
3. Karnik R., J. Clin. Basic Cardiol., 4, 31-34 (2001).
4. Gordon D. J., Rifkind B. M., N. Engl. J. Med., 321, 1311-1316 (1989).
5. Assmann G., Nofer J. R., Annu. Rev. Med., 54, 321-341 (2003).
6. Black D. M., Am. J. Cardiol., 91, 40E-43E (2003).
7. Assmann G., Gotto A. M., Jr., Circulation, 109 (23 Suppl. I), III8-III14 (2004).
8. Kwiterovich P. O., Jr., J. Am. Diet Assoc., 97 (Suppl.), S31-S41 (1997).
9. Criqui M. H., Golomb B. A., Am. J. Med., 105, 48S-57S (1998).
10. Iizuka N., Miyamoto K., Hazama S., Yoshino S., Yoshimura K., Okita K., Fukumoto T., Yamamoto S., Tangoku A., Oka M., Cancer Lett., 158, 35-41 (2000).
11. Ozaki Y., Biol. Pharm. Bull., 18, 559-562 (1995).
12. Takahashi H., Clin. J. Chin. Med., 12, 145-151 (1991).
13. Gao M., Ikeda K., Noguchi T., Mori K., Yamori Y., J. Trad. Med., 18, 245-250 (2001).
14. Makino T., Wakushima H., Okamoto T., Okukubo Y., Saito K., Kano Y., Biol. Pharm. Bull., 25, 523-525 (2002).
15. Makino T., Wakushima H., Okamoto T., Okukubo Y., Deguchi Y., Kano Y., J. Ethnopharmacol., 82, 35-40 (2002).
16. Satoh A., Yokozawa T., Cho E. J., Okamoto T., Sei Y., Arch. Gerontol. Geriatr., 39, 69-82 (2004).
17. Satoh A., Yokozawa T., Kim Y. A., Cho E. J., Okamoto T., Sei Y., J. Pharm. Pharmacol., 57, 1335-1343 (2005).
18. Beynen A. C., Lemmens A. G., Katan M. B., De Bruijne J. J., Van Zutphen L. F., Comp. Biochem. Physiol. B., 87, 41-48 (1987).
19. Arafa H. M., Med. Sci. Monit., 11, BR228- BR234 (2005).
20. Noma A., Nakayama K., Kita M., Okabe H., Clin. Chem., 24, 1504-1508 (1978).
21. Noma A., Okabe H., Nakayama K., Ueno Y., Shinohara H., Clin. Chem., 25, 1480-1481 (1979).
22. Havel R. J., Eder H. A., Bragdon J. H., J. Clin. Invest., 34, 1345-1353 (1955).
23. Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J., J. Biol. Chem., 193, 265-275 (1951).
24. Ohkawa H., Ohishi N., Yagi K., Anal. Biochem., 95, 351-358 (1979).
25. Naito C., Yamanaka T., Jpn. J. Geriatr., 15, 187-191 (1978).
26. The expert panel, Arch. Intern. Med., 148, 36-69 (1988).
27. The expert panel, JAMA, 269, 3015-3023 (1993).
28. Schaefer E. J., Lichtenstein A. H., Lamon-Fava S., McNamara J. R., Ordovas J. M., Am. J. Clin. Nutr., 61 (3 Suppl.), 726S-740S (1995).
29. Castelli W. P., Garrison R. J., Wilson P. W., Abbott R. D., Kalousdian S., Kannel W. B., JAMA, 256, 2835-2838 (1986).
30. Krieger M., Proc. Natl. Acad. Sci. U.S.A., 95, 4077-4080 (1998).
31. Yokozawa T., Nakagawa T., Kitani K., J. Agric. Food Chem., 50, 3549-3552 (2002).
32. Yokozawa T., Ishida A., Cho E. J., Nakagawa T., Phytomed., 10, 17-22 (2003).
33. Ross R., Nature (London), 362, 801-809 (1993).
34. Beynene A. C., Lemmens A. G., Katan M. N., De Bruijne J. J., Van Zutphen L. F., Comp. Biochem. Physiol. B., 87, 41-48 (1987).
35. Bolkent S., Yanardag R., Karabulut-Bulan O., Yesilyaprak B., J. Ethnopharmacol., 99, 391-398 (2005).
36. Wannamethee S. G., Shaper A. G., Ebrahim S., Stroke, 31, 1882-1888 (2000).
37. Navab M., Hama S. Y., Anantharamaiah G. M., Hassan K., Hough G. P., Watson A. D., Reddy S. T., Sevanian A., Fonarow G. C., Fogelman A. M., J. Lipid Res., 41, 1495-1508 (2000).
38. Navab M., Berliner J. A., Subbanagounder G., Hama S., Lusis A. J., Castellani L. W., Reddy S., Shih D., Shi W., Watson A. D., Van Lenten B. J., Vora D., Fogelman A. M., Arterioscler. Thromb. Vasc. Biol., 21, 481-488 (2001).
39. Nofer J. R., Kehrel B., Fobker M., Levkau B., Assmann G., von Eckardstein A., Atherosclerosis, 161, 1-16 (2002).
40. Gylling H., Int. J. Clin. Pract., 58, 859-866 (2004).
41. Rudel L. L., Parks J. S., Johnson F. L., Babiak J., J. Lipid Res., 27, 465-474 (1986).
42. Steinberg D., Parthasarathy S., Carew T. E., Khoo J. C., Witztum J. L., N. Engl. J. Med., 320, 915-924 (1989).
43. Esterbauer H., Gebicki J., Puhl H., Jurgens G., Free Radic. Biol. Med., 13, 341-390 (1992).
44. Sakuma Y., Hagihara H., Nagayoshi A., Ohne K., Mutoh S., Ito Y., Nakahara K., Life Sci., 60, 351-356 (1997).
45. Fungwe T. V., Cagen L., Wilcox H. G., Heimberg M., J. Lipid Res., 33, 179-191 (1992).
46. Prasad K., Kalra J., Angiology, 40, 835-843 (1989).
47. Erdincler D. S., Seven A., Inci F., Beger T., Candan G., Clin. Clim. Acta, 265, 77-84 (1997).
48. Prasad K., Circulation, 99, 1355-1362 (1999).